Andrew G. Bostom

12.8k total citations · 3 hit papers
116 papers, 9.9k citations indexed

About

Andrew G. Bostom is a scholar working on Rheumatology, Surgery and Nephrology. According to data from OpenAlex, Andrew G. Bostom has authored 116 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Rheumatology, 49 papers in Surgery and 29 papers in Nephrology. Recurrent topics in Andrew G. Bostom's work include Folate and B Vitamins Research (77 papers), Esophageal and GI Pathology (34 papers) and Renal Transplantation Outcomes and Treatments (20 papers). Andrew G. Bostom is often cited by papers focused on Folate and B Vitamins Research (77 papers), Esophageal and GI Pathology (34 papers) and Renal Transplantation Outcomes and Treatments (20 papers). Andrew G. Bostom collaborates with scholars based in United States, Canada and Germany. Andrew G. Bostom's co-authors include Jacob Selhub, Paul F. Jacques, Irwin H. Rosenberg, Peter W.F. Wilson, Douglas Shemin, R. Curtis Ellison, Roger R. Williams, Marie Nadeau, Philip A. Wolf and John H. Eckfeldt and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

Andrew G. Bostom

110 papers receiving 9.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations

1996 1.2k citations Paul F. Jacques, Andrew G. Bostom et al. profile →
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis

1995 943 citations Jacob Selhub, Paul F. Jacques et al. profile →
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort

2001 523 citations Paul F. Jacques, Andrew G. Bostom et al. American Journal of Clinical Nutrition profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew G. Bostom United States	44	6.0k	3.8k	1.7k	1.4k	1.3k	116	9.9k
Gere Sunder‐Plassmann Austria	47	2.1k 0.3×	1.2k 0.3×	1.8k 1.0×	1.5k 1.0×	671 0.5×	322	8.9k
Lars Brattström Sweden	31	5.0k 0.8×	2.4k 0.6×	186 0.1×	794 0.6×	391 0.3×	51	6.0k
Bryan Kestenbaum United States	67	852 0.1×	2.2k 0.6×	8.3k 4.8×	441 0.3×	2.7k 2.1×	248	15.6k
Sharon M. Moe United States	59	1.5k 0.2×	1.9k 0.5×	10.4k 6.0×	385 0.3×	1.0k 0.8×	287	14.4k
Roger R. Williams United States	38	1.4k 0.2×	2.2k 0.6×	177 0.1×	433 0.3×	2.9k 2.2×	120	9.0k
Myles Wolf United States	75	1.3k 0.2×	2.6k 0.7×	13.6k 7.9×	1.4k 1.0×	1.7k 1.3×	247	22.6k
A. J. M. Donker Netherlands	40	772 0.1×	1.3k 0.3×	1.5k 0.8×	279 0.2×	1.6k 1.2×	128	5.8k
Bruce F. Culleton Canada	38	598 0.1×	2.1k 0.6×	7.3k 4.3×	782 0.5×	3.4k 2.6×	92	11.9k
Kunitoshi Iseki Japan	58	564 0.1×	2.2k 0.6×	8.4k 4.9×	945 0.7×	2.9k 2.2×	321	13.1k
Piet J. Kostense Netherlands	44	852 0.1×	1.1k 0.3×	771 0.4×	204 0.1×	2.6k 2.0×	102	7.1k

Countries citing papers authored by Andrew G. Bostom

Since Specialization

Citations

This map shows the geographic impact of Andrew G. Bostom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew G. Bostom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew G. Bostom more than expected).

Fields of papers citing papers by Andrew G. Bostom

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew G. Bostom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew G. Bostom. The network helps show where Andrew G. Bostom may publish in the future.

Co-authorship network of co-authors of Andrew G. Bostom

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew G. Bostom. A scholar is included among the top collaborators of Andrew G. Bostom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew G. Bostom. Andrew G. Bostom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kang, Augustine, Andrew G. Bostom, Charles B. Eaton, et al.. (2020). Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients. Nephrology Dialysis Transplantation. 35(8). 1436–1443. 14 indexed citations

Merhi, Basma, Theresa I. Shireman, Myra A. Carpenter, et al.. (2017). Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort. American Journal of Kidney Diseases. 70(3). 377–385. 26 indexed citations

Foster, Meredith C., Daniel E. Weiner, Andrew G. Bostom, et al.. (2017). Filtration Markers, Cardiovascular Disease, Mortality, and Kidney Outcomes in Stable Kidney Transplant Recipients: The FAVORIT Trial. American Journal of Transplantation. 17(9). 2390–2399. 22 indexed citations

Bostom, Andrew G., Myra A. Carpenter, Lawrence G. Hunsicker, et al.. (2008). Baseline Characteristics of Participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial. American Journal of Kidney Diseases. 53(1). 121–128. 34 indexed citations

Bostom, Andrew G., et al.. (2005). The legacy of Jihad : Islamic holy war and the fate of non-Muslims. 20 indexed citations

Friedman, Allon N., et al.. (2003). The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: A randomized, controlled study. American Journal of Kidney Diseases. 41(2). 442–446. 49 indexed citations

Shemin, Douglas, Andrew G. Bostom, & Jacob Selhub. (2001). Treatment of hyperhomocysteinemia in end-stage renal disease. American Journal of Kidney Diseases. 38(4). S91–S94. 38 indexed citations

Dwyer, Johanna, Jacob Selhub, Paul F. Jacques, et al.. (2001). Serum cystatin C is an independent predictor of total homocysteine levels in stable Korean renal transplant recipients with normal serum creatinine. Journal of Renal Nutrition. 11(3). 149–154. 8 indexed citations

Jacques, Paul F., Andrew G. Bostom, Peter W.F. Wilson, et al.. (2001). Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. American Journal of Clinical Nutrition. 73(3). 613–621. 523 indexed citations breakdown →

10.

Bostom, Andrew G., Florian Kronenberg, Reginald Gohh, et al.. (2001). Chronic renal transplantation: a model for the hyperhomocysteinemia of renal insufficiency. Atherosclerosis. 156(1). 227–230. 18 indexed citations

11.

Lapane, Kate L., Reginald Gohh, Jacob Selhub, et al.. (1999). Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients. Transplantation Proceedings. 31(5). 2121–2123. 2 indexed citations

12.

Gohh, Reginald, et al.. (1999). Enhanced Reduction of Fasting Total Homocysteine Levels With Supraphysiological Versus Standard Multivitamin Dose Folic Acid Supplementation in Renal Transplant Recipients. Arteriosclerosis Thrombosis and Vascular Biology. 19(12). 2918–2921. 55 indexed citations

13.

Bostom, Andrew G., Reginald Gohh, Paul F. Jacques, et al.. (1999). Prevalence of mild fasting hyperhomocysteinemia in renal transplant versus coronary artery disease patients after fortification of cereal grain flour with folic acid. Atherosclerosis. 145(1). 221–224. 25 indexed citations

14.

Bostom, Andrew G., Douglas Shemin, Reginald Gohh, et al.. (1998). Lower Fasting Total Plasma Homocysteine Levels in Stable Renal Transplant Recipients Versus Maintenance Dialysis Patients. Transplantation Proceedings. 30(1). 160–162. 8 indexed citations

15.

Bostom, Andrew G., Reginald Gohh, Marie Nadeau, et al.. (1997). Treatment of Hyperhomocysteinemia in Renal Transplant Recipients. Annals of Internal Medicine. 31 indexed citations

16.

Bostom, Andrew G., et al.. (1997). Treatment of Hyperhomocysteinemia in Renal Transplant Recipients. Annals of Internal Medicine. 127(12). 1089–1092. 106 indexed citations

17.

Bostom, Andrew G.. (1996). Elevated Plasma Lipoprotein(a) and Coronary Heart Disease in Men Aged 55 Years and Younger. JAMA. 276(7). 544–544. 331 indexed citations

18.

Bostom, Andrew G., Anne L. Hume, Charles B. Eaton, et al.. (1995). The Effect of High‐Dose Ascorbate Supplementation on Plasma Lipoprotein(a) Levels in Patients With Premature Coronary Heart Disease. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(4). 458–464. 13 indexed citations

19.

Bostom, Andrew G., Douglas Shemin, Kate L. Lapane, et al.. (1995). Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis. 114(1). 93–103. 154 indexed citations

20.

Bostom, Andrew G., Lisa R. Yanek, Anne L. Hume, et al.. (1994). High dose ascorbate supplementation fails to affect plasma homocyst(e)ine levels in patients with coronary heart disease. Atherosclerosis. 111(2). 267–270. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact